methotrexate has been researched along with Cancer of Prostate in 128 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 52 (40.63) | 18.7374 |
1990's | 40 (31.25) | 18.2507 |
2000's | 26 (20.31) | 29.6817 |
2010's | 7 (5.47) | 24.3611 |
2020's | 3 (2.34) | 2.80 |
Authors | Studies |
---|---|
Basaria, S; Gagliano-Jucá, T; Hirsch, MS; McGregor, BA | 1 |
Ben Mrad, M; Bosacki, C; Bousarsar, A; Daguenet, E; Guillaume, E; Jmour, O; Lahmamssi, C; Magné, N; Vallard, A; Vial, N | 1 |
Hammami, MB; Mahadevan, U | 1 |
Bockorny, B; Dasanu, CA; Joseph, R | 1 |
Asch, AS; Chen, X; Green, T; Ruiz-Echevarría, MJ; Ryan, S | 1 |
Huang, B; Joice, M; Kotlyar, A; Otis, J; Thomas, TP | 1 |
Barratt, G; Døskeland, SO; Herfindal, L; Myhren, L; Nicolas, V; Nilssen, IM | 1 |
Al-Taher, AY; El-Sheikh, AA; Morsy, MA | 1 |
Ioannidis, G; Kitrou, G; Michael, M; Orphanos, G | 1 |
Castellón, EA; Contreras, HR; Huidobro, C; McCubrey, JA; Mendoza, P; Sánchez, C; Vergara, J | 1 |
Barlett, N; Chen, CH; Grenier, K; Mujic, V; Sussman, H; Toepker, S; Waller, EK | 1 |
Doi, Y; Hashimoto, T; Higuchi, Y; Hirota, S; Maruyama, T; Nojima, M; Ueda, Y; Yabumoto, H; Yamada, Y; Yamamoto, S; Yoshida, T; Zouzumi, M | 1 |
Borsellino, N; Gebbia, V; Serretta, V; Valerio, MR | 1 |
Dent, P; Fisher, PB; Gopalkrishnan, RV; Narayan, G; Su, ZZ | 1 |
Culine, S | 1 |
Bevan, J; Homer, D; Jobanputra, P; Maggs, F | 1 |
Aynehchi, S; Choudhury, MS; Drinis, S; Finkelstein, MP; Konno, S; Samadi, AA; Tazaki, H | 1 |
Horne, DW; Reed, KA | 3 |
Jiraviriyakul, A; Phattarasakul, K; Sutthiphongchai, T; Tohtong, R | 1 |
Habuchi, T; Kamoto, T; Nakashima, M; Nishiyama, H; Ogawa, O; Yagihashi, Y; Yamamoto, S | 1 |
Denmeade, SR; Gady, AM; Gillies, SD; Lo, KM; Mhaka, A; Rosen, DM | 1 |
Leach, F | 1 |
Gandhok, N; Sartor, O | 1 |
Mazeron, JJ | 1 |
Li, CJ; Pardee, AB; Reddy, PV; Wang, A | 1 |
Bai, YJ; Hao, XK; Liu, JY; Wu, GJ; Yin, Y; Yue, QH | 1 |
Anand, S; Chang, Y; Hasan, T; Mai, Z; Maytin, EV; Ortel, BJ; Sinha, AK | 1 |
Cai, C; Hsieh, CL; Omwancha, J; Shemshedini, L | 1 |
Ling, MT; Wang, X; Wong, YC; Zhang, X | 1 |
Creaven, PJ; Madajewicz, S; Mittelman, A | 1 |
Oberfield, RA | 1 |
deKernion, JB; Lindner, A | 1 |
Beckley, S; Brady, MF; Chu, TM; deKernion, JB; Dhabuwala, C; Gaeta, JF; Gibbons, RP; Loening, SA; McKiel, CF; McLeod, DG; Murphy, GP; Pontes, JE; Prout, GR; Scardino, PT; Schlegel, JU; Schmidt, JD; Scott, WW; Slack, NH; Soloway, MS | 1 |
Könyves, I; Müntzing, J; Rozencweig, M | 1 |
Schmidt, JD | 2 |
Drago, JR; Palmer, J | 1 |
Babayan, RK; deVere White, R; Krane, RJ; Krikorian, J; Olsson, CA | 1 |
Herr, HW | 1 |
Engelking, C; Fleit, JP; Straus, MJ | 1 |
Catane, R; Madajewicz, S; Mittelman, A; Murphy, GP; Wajsman, Z | 1 |
Brodkin, R; Cooper, MR; Howard, V; Jackson, DV; Muss, HB; Resnick, MI; Richards, F; Spurr, CL; Stuart, JJ; White, DR | 1 |
Grossman, HB; Herr, HW; Kleinert, EL; Lesser, ML; Whitmore, WF | 1 |
Drago, JR; Goldman, LB | 1 |
Drago, JR; Gershwin, ME; Goldman, LB | 1 |
Drago, JR; Gershwin, ME; Goldman, L | 1 |
Jones, MA; Williams, G | 1 |
Ishihara, S; Kuriyama, M; Nagatani, Y; Ozeki, S; Takahashi, Y; Takeda, A; Takeuchi, T; Taniguchi, M; Ueno, K; Yamamoto, N | 1 |
Asano, M; Ban, Y; Deguchi, T; Ehara, H; Ishihara, S; Kawada, Y; Kuriyama, M; Mima, H; Ozeki, S; Takahashi, Y | 1 |
Petrylak, D; Yagoda, A | 1 |
Kitamura, Y; Komatsubara, S; Sakata, Y; Watanabe, M | 1 |
Koshiba, K; Mukai, N; Rokkaku, S; Soh, S; Uchida, T | 1 |
García Alonso, J; Gómez Cisneros, S; Kilani Elmasri, S; Martín Castillo, J; Monsalve Rodríguez, M; Parra Muntaner, L; Verdú Martínez, M | 1 |
Comaru-Schally, AM; Groot, K; Halmos, G; Nagy, A; Pinski, J; Radulovic, S; Schally, AV; Szepeshazi, K; Yano, T | 1 |
Fukushima, S; Miyamoto, H; Moriyama, M; Nomura, S | 1 |
Blumenstein, BA; Boileau, M; Crawford, ED; Fletcher, WS; Rivkin, SE; Wozniak, AJ | 1 |
Donner, G; Flamm, J; Fritz, E; Ludwig, H; Micksche, M; Sagaster, P | 1 |
Komatus, H; Maesawa, H; Tago, K; Tanabe, N; Ueno, A | 1 |
Alken, P; Köhrmann, KU; Kreukler, C; Nebe, T; Siegsmund, MJ; Steidler, A | 1 |
Dahrouge, S; Stewart, DJ | 1 |
Akaza, H; Takeshima, H | 1 |
Denis, L | 1 |
Deguchi, T; Kawada, Y; Kuriyama, M; Nakano, M; Shinoda, I; Takahashi, Y; Takeuchi, T; Yamamoto, N; Yasuda, M; Yoh, M | 2 |
Abe, K; Asano, K; Kiyota, H; Ohishi, Y; Onodera, S | 1 |
Berzin, TM; Heston, WD; Lin, S; May, F; Mukherjee, B; Pinto, JT; Qiao, CH; Suffoletto, BP; Tong, WP | 1 |
Hartung, G; Heene, DL; Schrenk, HH; Sinn, H; Stehle, G; Wunder, A | 1 |
Kajikawa, H; Kataoka, K; Kiwamoto, H; Konya, E; Kurita, T; Nose, K | 1 |
Akaza, H; Hattori, K | 1 |
Imamura, R; Inoue, H; Mise, T; Miyoshi, S; Mizutani, S; Nishimura, K; Uemura, M | 1 |
Chang, YH; Chiang, H; Epstein, JI; Pan, CC | 1 |
Chen, Y; Hao, XK; Shi, PT; Tao, QY; Zhang, YH | 1 |
Burger, AM; Fiebig, HH; Hartung, G; Sinn, H; Stehle, G | 1 |
Egawa, S; Ohori, M; Uchida, T | 1 |
Akaza, H; Hattori, K; Kawai, K; Miyanaga, N; Shimazui, T; Tsukamoto, S; Uchida, K | 1 |
Carter, SK; Wasserman, TH | 1 |
Drago, JR; Eckels, DD; Gershwin, ME; Goldman, LB; Maurer, RE | 1 |
Bergreen, PW; Buell, GV; Saiers, JH; Saiki, JH | 1 |
Block, NL; Camuzzi, F; Claflin, A; Politano, VA; Stover, B; Troner, M | 1 |
Jensen, TS; Ogaard, S | 1 |
Kane, RD; Paulson, DF; Stocks, LH | 1 |
Kane, RD; Mickey, DD; Paulson, DF | 1 |
Bailin, PL; Hogan, MD; Roenigk, HH; Tindall, JP | 1 |
Bokser, L; Halmos, G; Janáky, T; Juhász, A; Milovanovic, S; Pinski, J; Redding, TW; Rékási, Z; Serfözö, P; Srkalovic, G | 1 |
Ansari, R; Drasga, R; Einhorn, L; McClean, J; Miller, M; Saxman, S; Wheeler, B | 1 |
Aga, Y; Miki, H; Yokota, K; Yokota, T | 1 |
Jeffery, GM; Mead, GM | 1 |
Araki, S; Kato, M; Kusuyama, H; Okada, K | 1 |
Amato, R; Dexeus, FH; Fitz, K; Kilbourn, R; Logothetis, CJ; Sella, A; Striegel, A | 1 |
Kawada, Y; Kobayashi, S; Kuriyama, M; Nagatani, Y; Shinoda, I; Takahashi, Y; Takeuchi, T | 1 |
Fujii, A; Higuchi, A; Itoh, N; Miyasaki, S; Morishita, S; Oka, N; Okamoto, Y; Tanaka, H; Tomioka, O; Yamanaka, K | 1 |
Frohmüller, H; Heimbach, D; Wirth, M | 1 |
Matsumura, Y; Tsushima, T | 1 |
Boven, E; de Pauw, M; Droz, JP; Fosså, SD; Jones, WG; Klijn, JG; Sylvester, R; Verbaeys, AC | 1 |
Shafik, A | 1 |
Griffiths, K; Harper, ME; Rowland, AJ; Wilson, DW | 1 |
Kaye, SB; Kirk, D; Lawson, AH; Smith, MF | 1 |
Carvalho, L; Foulkes, K; Kendle, K; Mickey, DD; Petrow, V | 1 |
Kato, T; Koshikawa, T; Miyake, K; Nagai, T; Sahashi, M; Sakata, T; Takashi, M | 1 |
Kawada, Y; Kawamoto, S; Kuriyama, M; Nagatani, Y; Sakai, S; Shinoda, I; Takahashi, Y; Takeuchi, T; Ueno, K; Yamamoto, N | 1 |
Liberman, SN; Walther, PJ; Ware, JL; Webb, KS | 1 |
Cant, J; Hickey, D; Soloway, MS | 1 |
Hashimura, T; Hida, S; Kanamaru, H; Nishimura, K; Nishio, Y; Oishi, K; Okada, K; Yamauchi, T; Yoshida, O; Yoshiki, T | 1 |
Kusuyama, H; Numa, H; Okada, K; Sakamoto, S | 1 |
Apple, JS; Baber, C; Paulson, DF; Putman, CE | 1 |
Fujita, M; Hashimoto, H; Kaneko, S; Mizunaga, M; Sasaki, M; Tokunaka, S; Watanabe, Y; Yachiku, S | 1 |
Byard, MA; Drago, JR; Smith, JJ | 1 |
Portnoĭ, AS | 1 |
Hofmann, W; Langkopf, B | 1 |
Huben, RP; Murphy, GP | 1 |
Murphy, GP; Priore, RL; Scardino, PT | 1 |
Fair, WR; Herr, HW; Morse, MJ; Reuter, V; Scher, HI; Sogani, PC; Sternberg, CN; Watson, RC; Whitmore, WF; Yagoda, A | 1 |
Berry, WR; Cox, EB; Graham, SD; Laszlo, J; Paulson, DF; Walker, A | 1 |
Dhabuwala, CB; Drelichman, A; Ghayad, PY; Pierce, JM; Smith, JB | 2 |
Boucher, AE; Drago, J; Gordon, R; Harvey, H; Lipton, A; Manni, A; Rohner, T; Santen, RJ; Simmonds, M; Wettlaufer, J | 1 |
Chu, TM; Deguchi, T; Horoszewicz, JS; Lee, CL; Leong, SS | 1 |
Drago, JR; Lombard, J | 1 |
Case, D; Cooper, MR; Muss, HB; Nelson, EC; Pope, E; Puckett, JB; Resnick, MI; Richards, F; Spurr, CL; Zekan, P | 1 |
Pavone-Macaluso, M | 1 |
Elhilali, MM; Mackinnon, KJ; Oliver, JA; Sherwin, AL | 1 |
Lopes Cardozo, E | 1 |
Kanwal, G; Kim, RH; Li, MC | 1 |
Armstrong, JG | 1 |
Brunat, M; Dargent, M; Mayer, H; Pommatau, E | 1 |
Scott, WP | 1 |
18 review(s) available for methotrexate and Cancer of Prostate
Article | Year |
---|---|
[Radiotherapy and immune suppression: A short review].
Topics: Autoimmune Diseases; Female; Genital Neoplasms, Female; Humans; Immunocompromised Host; Immunosuppression Therapy; Immunosuppressive Agents; Male; Methotrexate; Neoplasms; Organs at Risk; Prostatic Neoplasms; Radiotherapy; Transplant Recipients; Transplants; Withholding Treatment | 2020 |
Men With Inflammatory Bowel Disease: Sexual Function, Fertility, Medication Safety, and Prostate Cancer.
Topics: Depression; Gastrointestinal Agents; Humans; Infertility, Male; Inflammatory Bowel Diseases; Male; Methotrexate; Prostatic Neoplasms; Risk Factors; Sexual Dysfunction, Physiological; Sulfasalazine | 2020 |
[Gemcitabine and urogenital tumors].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cystectomy; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Germinoma; Hematologic Diseases; Humans; Kidney Neoplasms; Male; Methotrexate; Organoplatinum Compounds; Patient Selection; Prostatic Neoplasms; Salvage Therapy; Treatment Outcome; Urinary Bladder Neoplasms; Urogenital Neoplasms; Vinblastine | 2002 |
[A case report of a young patient with invasive bladder cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Epirubicin; Humans; Male; Methotrexate; Neoplasm Invasiveness; Prostatic Neoplasms; Urinary Bladder Neoplasms; Urinary Diversion | 2003 |
New potential treatment modalities for disseminated prostatic cancer.
Topics: Androgen Antagonists; Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Castration; Combined Modality Therapy; Cyclophosphamide; Floxuridine; Folic Acid Antagonists; Hormones; Humans; Interferons; Isomerism; Male; Methotrexate; Naphthacenes; Nitrosourea Compounds; Organoplatinum Compounds; Prostatic Neoplasms; Thymus Hormones; Tumor Stem Cell Assay | 1984 |
Chemotherapy of hormonally unresponsive prostatic carcinoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carmustine; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Diethylstilbestrol; Doxorubicin; Estramustine; Fluorouracil; Humans; Imidazoles; Lomustine; Male; Methotrexate; Mitomycin; Mitomycins; Prednimustine; Prednisone; Procarbazine; Prostatic Neoplasms; Random Allocation; Streptozocin; Vincristine | 1984 |
Chemotherapy principles in the treatment of prostatic cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Castration; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Evaluation, Preclinical; Estradiol Congeners; Fluorouracil; Humans; Male; Methotrexate; Prostatic Neoplasms; Rats; Structure-Activity Relationship; Testosterone Congeners | 1984 |
Cytotoxic agents effective in prostate cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Fluorouracil; Humans; Lomustine; Male; Methotrexate; Prostatic Neoplasms; Semustine | 1983 |
Cytotoxic chemotherapy for advanced hormone-resistant prostate cancer.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Bone Neoplasms; Cisplatin; Clinical Trials as Topic; Coumarins; Doxorubicin; Drug Administration Schedule; Drug Resistance; Fluorouracil; Humans; Intercalating Agents; Male; Methotrexate; Neoplasm Staging; Polyamines; Prostate-Specific Antigen; Prostatic Neoplasms; Remission Induction; Somatostatin | 1993 |
[Recurrent urological cancer--diagnose and treatment].
Topics: Abdomen; Administration, Intravesical; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Biomarkers, Tumor; Chemotherapy, Adjuvant; Cisplatin; Cystoscopy; Doxorubicin; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Nuclear Proteins; Prostate-Specific Antigen; Prostatic Neoplasms; Ultrasonography; Urinary Bladder Neoplasms; Vinblastine | 1998 |
[A case of primary transitional cell carcinoma of the prostate].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Doxorubicin; Humans; Male; Methotrexate; Prostatectomy; Prostatic Neoplasms; Treatment Outcome; Vinblastine | 1999 |
[New combination chemotherapy in urological cancers].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Docetaxel; Doxorubicin; Drug Administration Schedule; Female; Gemcitabine; Humans; Interferon-alpha; Interleukin-2; Kidney Neoplasms; Male; Methotrexate; Paclitaxel; Prostatic Neoplasms; Taxoids; Testicular Neoplasms; Urinary Bladder Neoplasms; Vinblastine | 2000 |
[Primary transitional cell carcinoma of prostate: a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Humans; Male; Methotrexate; Prostatic Neoplasms; Treatment Outcome; Urologic Surgical Procedures; Vinblastine | 2000 |
[Chemotherapy and radiotherapy for urological cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Kidney Neoplasms; Male; Methotrexate; Prostatic Neoplasms; Testicular Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine | 2002 |
[A case of advanced prostatic cancer in a 44-year-old treated effectively with combination chemo-endocrine therapy].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Doxorubicin; Estramustine; Humans; Male; Methotrexate; Nitrogen Mustard Compounds; Orchiectomy; Peplomycin; Prostatic Neoplasms; Remission Induction; Tegafur | 1990 |
[Chemotherapy of urogenital cancers].
Topics: Administration, Intravesical; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Humans; Infusions, Intra-Arterial; Kidney Neoplasms; Male; Methotrexate; Prostatic Neoplasms; Testicular Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms | 1991 |
[A case of primary transitional cell carcinoma of the prostate].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Humans; Male; Methotrexate; Middle Aged; Prostatectomy; Prostatic Neoplasms; Vinblastine | 1989 |
[Chemotherapy of prostatic cancer].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dacarbazine; Diethylstilbestrol; Doxorubicin; Estramustine; Fluorouracil; Humans; Hydroxyurea; Male; Melphalan; Methotrexate; Mitomycin; Mitomycins; Prednisolone; Procarbazine; Prostatic Neoplasms; Streptozocin; Vincristine | 1985 |
20 trial(s) available for methotrexate and Cancer of Prostate
Article | Year |
---|---|
Chemotherapy of hormonally unresponsive prostatic carcinoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carmustine; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Diethylstilbestrol; Doxorubicin; Estramustine; Fluorouracil; Humans; Imidazoles; Lomustine; Male; Methotrexate; Mitomycin; Mitomycins; Prednimustine; Prednisone; Procarbazine; Prostatic Neoplasms; Random Allocation; Streptozocin; Vincristine | 1984 |
Comparison of estramustine phosphate, methotrexate and cis-platinum in patients with advanced, hormone refractory prostate cancer.
Topics: Aged; Cisplatin; Clinical Trials as Topic; Estramustine; Hormones; Humans; Male; Methotrexate; Middle Aged; Nitrogen Mustard Compounds; Prostatic Neoplasms | 1983 |
Cyclophosphamide, methotrexate and 5-fluorouracil combination chemotherapy versus chloroethyl-cyclohexy-nitrosourea in the treatment of metastatic prostatic cancer.
Topics: Aged; Antineoplastic Agents; Carcinoma; Cyclophosphamide; Drug Therapy, Combination; Fluorouracil; Follow-Up Studies; Humans; Lomustine; Male; Methotrexate; Middle Aged; Prospective Studies; Prostatic Neoplasms; Random Allocation | 1982 |
Cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil in advanced prostatic cancer: a randomized trial.
Topics: Aged; Bone Neoplasms; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Prognosis; Prospective Studies; Prostatic Neoplasms | 1981 |
Intra-arterial chemotherapy using a reservoir for endocrine-refractory prostate cancer.
Topics: Abdominal Muscles; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Implants; Fluorouracil; Humans; Iliac Artery; Infusions, Intra-Arterial; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatic Neoplasms; Survival Rate; Thigh | 1994 |
[Clinical trial of the systemic chemotherapy for advanced prostatic cancer patients].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Humans; Male; Methotrexate; Middle Aged; Prognosis; Prostatic Neoplasms | 1993 |
Cyclophosphamide, methotrexate, and 5-fluorouracil in the treatment of metastatic prostate cancer. A Southwest Oncology Group study.
Topics: Acid Phosphatase; Adenocarcinoma; Aged; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Cyclophosphamide; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Prostatic Neoplasms; Remission Induction; Survival Rate | 1993 |
Maximal androgen blockade in combination with methotrexate for treatment of metastatic prostate cancer.
Topics: Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Flutamide; Humans; Male; Methotrexate; Middle Aged; Orchiectomy; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms | 1996 |
[Comparison of hormone therapy alone and in combination with chemotherapy of cisplatin and methotrexate in newly diagnosed patients with stage D2 prostatic cancer].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Diethylstilbestrol; Disease-Free Survival; Humans; Male; Methotrexate; Orchiectomy; Prostatic Neoplasms | 1996 |
European Organization for Research and Treatment of Cancer (EORTC) prostate cancer trials, 1976-1996.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Castration; Cyproterone Acetate; Diethylstilbestrol; Doxorubicin; Epirubicin; Estramustine; Flutamide; Humans; Imidazoles; Male; Medroxyprogesterone Acetate; Methotrexate; Mitomycin; Neoplasms, Hormone-Dependent; Procarbazine; Prostatic Neoplasms; Vindesine | 1998 |
[Intra-arterial chemotherapy via reservoir system for advanced bladder cancer and prostate cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Catheters, Indwelling; Cisplatin; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Male; Methotrexate; Middle Aged; Prostatic Neoplasms; Urinary Bladder Neoplasms | 1999 |
Phase III trial of cyclophosphamide versus cyclophosphamide, doxorubicin, and methotrexate in hormone-refractory prostatic cancer. A Hoosier Oncology Group study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Male; Methotrexate; Middle Aged; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Remission Induction; Survival Analysis | 1992 |
[Treatment of newly diagnosed stage D2 prostatic carcinoma with hormonal therapy alone, or chemotherapy agents in combination with hormones].
Topics: Administration, Oral; Aged; Aged, 80 and over; Castration; Chlormadinone Acetate; Combined Modality Therapy; Cyclophosphamide; Diethylstilbestrol; Drug Therapy, Combination; Estramustine; Humans; Infusions, Intravenous; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prognosis; Prostatic Neoplasms; Survival Rate | 1991 |
[Chemotherapy in metastasizing prostate carcinoma].
Topics: Aged; Antineoplastic Agents; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Male; Methotrexate; Prostatic Neoplasms; Survival Analysis | 1991 |
Anal submucosal injection: a new route for drug administration in pelvic malignancies. V. Advanced prostatic cancer: results of methotrexate treatment using the anal route--preliminary study.
Topics: Aged; Aged, 80 and over; Humans; Injections; Male; Methotrexate; Middle Aged; Prostatic Neoplasms | 1990 |
Failure of chemotherapy to prolong life in patients with metastatic prostate cancer who have failed androgen deprivation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Fluorouracil; Humans; Male; Methotrexate; Palliative Care; Prostatic Neoplasms; Time Factors | 1988 |
A comparison of diethylstilbestrol or orchiectomy with buserelin and with methotrexate plus diethylstilbestrol or orchiectomy in newly diagnosed patients with clinical stage D2 cancer of the prostate.
Topics: Antineoplastic Combined Chemotherapy Protocols; Buserelin; Diethylstilbestrol; Humans; Male; Methotrexate; Neoplasm Staging; Orchiectomy; Prostatic Neoplasms | 1988 |
Hormone-refractory metastatic prostatic cancer treated with methotrexate, cyclophosphamide plus adriamycin, cis-platinum plus 5-fluorouracil plus cyclophosphamide. National Prostatic Cancer Project randomized trial.
Topics: Acid Phosphatase; Alkaline Phosphatase; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Fluorouracil; Humans; Male; Methotrexate; Prostatic Neoplasms; Random Allocation | 1988 |
Value of cyclophosphamide or melphalan as combined chemotherapy in hormonally unresponsive prostatic carcinoma.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Fluorouracil; Humans; Male; Melphalan; Methotrexate; Prednisone; Prostatic Neoplasms; Random Allocation; Vincristine | 1986 |
Androgen depletion and repletion as a means of potentiating the effect of cytotoxic chemotherapy in advanced prostate cancer.
Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Evaluation; Drug Synergism; Fluorouracil; Fluoxymesterone; Humans; Hydrocortisone; Male; Methotrexate; Orchiectomy; Prostatic Neoplasms; Random Allocation; Spinal Cord Compression | 1987 |
91 other study(ies) available for methotrexate and Cancer of Prostate
Article | Year |
---|---|
Failure of Androgen-Deprivation Therapy Due to Ectopic hCG Secretion.
Topics: Androgen Antagonists; Androgens; Chorionic Gonadotropin; Humans; Male; Methotrexate; Prostatic Neoplasms | 2023 |
Methotrexate therapy leading to a rapid progression of a previously indolent prostate cancer: is immunosuppression to blame?
Topics: Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Immunosuppressive Agents; Male; Methotrexate; Prostatic Neoplasms | 2014 |
TMEFF2 and SARDH cooperate to modulate one-carbon metabolism and invasion of prostate cancer cells.
Topics: Antimetabolites, Antineoplastic; Carbon; Cell Proliferation; Cell Transformation, Neoplastic; Gene Knockdown Techniques; Humans; Male; Membrane Proteins; Methotrexate; Neoplasm Invasiveness; Neoplasm Proteins; Prostate; Prostatic Neoplasms; Sarcosine; Sarcosine Dehydrogenase; Tumor Cells, Cultured; Tumor Suppressor Proteins | 2013 |
PSMA-targeted stably linked "dendrimer-glutamate urea-methotrexate" as a prostate cancer therapeutic.
Topics: Antigens, Surface; Click Chemistry; Dendrimers; Drug Delivery Systems; Glutamate Carboxypeptidase II; Glutamic Acid; Humans; Male; Methotrexate; Nanoparticles; Prostatic Neoplasms; Urea | 2014 |
Efficacy of multi-functional liposomes containing daunorubicin and emetine for treatment of acute myeloid leukaemia.
Topics: Anthracyclines; Cell Line, Tumor; Chromatography, High Pressure Liquid; Daunorubicin; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Drug Resistance; Emetine; Flow Cytometry; Folate Receptor 2; Humans; Leukemia, Myeloid, Acute; Light; Liposomes; Male; Methotrexate; Polyethylene Glycols; Prostatic Neoplasms; Scattering, Radiation; Tumor Suppressor Protein p53 | 2014 |
Multi-drug resistance protein (Mrp) 3 may be involved in resveratrol protection against methotrexate-induced testicular damage.
Topics: Animals; Antimetabolites, Antineoplastic; Antioxidants; Body Weight; Cell Line, Tumor; Drug Resistance, Multiple; Humans; Male; Methotrexate; Multidrug Resistance-Associated Proteins; Prostatic Neoplasms; Protective Agents; Rats; Rats, Wistar; Resveratrol; Stilbenes; Testis; Testosterone | 2014 |
Prostate-specific antigen in the cerebrospinal fluid: a marker of local disease.
Topics: Aged; Antimetabolites, Antineoplastic; Cerebrospinal Fluid; Fatal Outcome; Humans; Male; Meningeal Neoplasms; Methotrexate; Prostate-Specific Antigen; Prostatic Neoplasms | 2009 |
Expression of multidrug resistance proteins in prostate cancer is related with cell sensitivity to chemotherapeutic drugs.
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Survival; Cisplatin; Docetaxel; Drug Resistance, Neoplasm; Humans; Male; Methotrexate; Mitoxantrone; Multidrug Resistance-Associated Proteins; Prostatic Neoplasms; Taxoids; Tumor Cells, Cultured; Vault Ribonucleoprotein Particles | 2009 |
Variations in the content of CD34+ cells in the peripheral blood of cancer patients receiving out-patient chemotherapy.
Topics: Adolescent; Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Leukocyte Count; Leukocytes; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasms; Outpatients; Prostatic Neoplasms; Young Adult | 1999 |
[A case of primary urothelial carcinoma of the prostate responsive to MVAC intra-arterial chemotherapy: a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Doxorubicin; Humans; Injections, Intra-Arterial; Male; Methotrexate; Prostatic Neoplasms; Urothelium; Vinblastine | 2011 |
Salvage therapy with oral metronomic cyclophosphamide and methotrexate for castration-refractory metastatic adenocarcinoma of the prostate resistant to docetaxel.
Topics: Adenocarcinoma; Administration, Metronomic; Administration, Oral; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Docetaxel; Humans; Male; Methotrexate; Prostatic Neoplasms; Salvage Therapy; Taxoids; Treatment Failure | 2011 |
Progression elevated gene-3, PEG-3, induces genomic instability in rodent and human tumor cells.
Topics: Animals; Antigens, Differentiation; Antimetabolites, Antineoplastic; Carcinoma; Cell Cycle Proteins; Cell Division; Cells, Cultured; Chromosome Aberrations; Drug Resistance, Neoplasm; Embryo, Mammalian; Female; Fibroblasts; Gene Amplification; Genome; Humans; Male; Methotrexate; Mice; Mice, Nude; Neoplasm Proteins; Neoplasms; Prostatic Neoplasms; Protein Phosphatase 1; Proto-Oncogene Proteins; Rats; RNA, Messenger; Tetrahydrofolate Dehydrogenase; Uterine Cervical Neoplasms | 2002 |
Monitoring and assessing the safety of disease-modifying antirheumatic drugs: a West Midlands experience.
Topics: Antirheumatic Agents; Arthritis, Infectious; Azathioprine; Drug Monitoring; Humans; Hypokalemia; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neutropenia; Pancytopenia; Pneumonia; Product Surveillance, Postmarketing; Prostatic Neoplasms; Sepsis; Sulfasalazine; United Kingdom | 2002 |
Chemosensitization of carmustine with maitake beta-glucan on androgen-independent prostatic cancer cells: involvement of glyoxalase I.
Topics: Agaricales; Androgens; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; beta-Glucans; Carmustine; Cell Survival; Dose-Response Relationship, Drug; Fluorouracil; Glucans; Humans; In Vitro Techniques; Lactoylglutathione Lyase; Male; Methotrexate; Prostatic Neoplasms; Tumor Cells, Cultured | 2002 |
Transport of methotrexate into LNCaP human prostate cancer cells.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Biological Transport; Humans; Hydrogen-Ion Concentration; Kinetics; Male; Methotrexate; Phosphates; Probenecid; Prostatic Neoplasms; Sulfates; Tumor Cells, Cultured | 2002 |
Uptake of 5-methyltetrahydrofolate into PC-3 human prostate cancer cells is carrier-mediated.
Topics: Arsenates; Biological Transport; Carrier Proteins; Folic Acid; Humans; Hydrogen-Ion Concentration; Leucovorin; Male; Methotrexate; Phosphates; Prostatic Neoplasms; Sodium; Sodium Azide; Sodium Cyanide; Sulfates; Tetrahydrofolates; Tumor Cells, Cultured | 2003 |
Dependence of metastatic cancer cell invasion on MLCK-catalyzed phosphorylation of myosin regulatory light chain.
Topics: Adenocarcinoma; Animals; Azepines; Cell Division; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Male; Methotrexate; Myosin Light Chains; Myosin-Light-Chain Kinase; Naphthalenes; Neoplasm Invasiveness; Neoplasm Metastasis; Phosphorylation; Prostatic Neoplasms; Rats | 2003 |
Use of methotrexate-based peptide substrates to characterize the substrate specificity of prostate-specific membrane antigen (PSMA).
Topics: Animals; Antigens, Surface; Aspartic Acid; Blotting, Western; Extracellular Fluid; Glutamate Carboxypeptidase II; Glutamic Acid; Humans; Immunoglobulin gamma-Chains; Immunoglobulin kappa-Chains; Male; Methotrexate; Mice; Peptide Fragments; Prodrugs; Prostatic Neoplasms; Recombinant Fusion Proteins; Substrate Specificity; Tumor Cells, Cultured | 2004 |
Targeting prostate-specific membrane antigen in cancer therapy: can molecular medicine be brought to the surface?
Topics: Antigens, Surface; Aspartic Acid; Drug Delivery Systems; Glutamate Carboxypeptidase II; Glutamic Acid; Humans; Male; Methotrexate; Peptide Fragments; Prodrugs; Prostatic Neoplasms; Recombinant Fusion Proteins; Substrate Specificity | 2004 |
Unexpected response of hormone-refractory prostate cancer to treatment with an antileukemic chemotherapy regimen.
Topics: Adenocarcinoma; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Fatal Outcome; Goserelin; Humans; Immunocompromised Host; Male; Methotrexate; Middle Aged; Neoplasm Proteins; Neoplasms, Second Primary; Neutropenia; Nitriles; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prostate-Specific Antigen; Prostatic Neoplasms; Recurrence; Sepsis; Tosyl Compounds; Vincristine | 2004 |
[Minutes of the 23th meeting of the European Society for Therapeutic Radiology and Oncology (ESTRO). Amsterdam, 24-28 October 2004].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Amifostine; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Mastectomy; Methotrexate; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Radiation-Protective Agents; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Rectal Neoplasms; Time Factors | 2005 |
Cancer chemotherapy by deoxynucleotide depletion and E2F-1 elevation.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Proteins; Cell Line, Tumor; Cisplatin; Colonic Neoplasms; DNA Replication; DNA-Binding Proteins; DNA, Neoplasm; E2F Transcription Factors; E2F1 Transcription Factor; Humans; Male; Methotrexate; Nucleotides; Prostatic Neoplasms; Transcription Factors | 2005 |
In vitro and in vivo prodrug therapy of prostate cancer using anti-gamma-Sm-scFv/hCPA fusion protein.
Topics: Animals; Antibodies, Neoplasm; Carboxypeptidases A; Cell Cycle; Cell Line, Tumor; Drug Delivery Systems; Humans; Immunoglobulin Variable Region; Male; Methotrexate; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplastic Stem Cells; Phenylalanine; Prodrugs; Prostate-Specific Antigen; Prostatic Neoplasms; Recombinant Fusion Proteins; Transplantation, Heterologous | 2006 |
Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells.
Topics: Aminolevulinic Acid; Apoptosis; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coproporphyrinogen Oxidase; Humans; Male; Methotrexate; Metribolone; Models, Biological; Photochemotherapy; Photosensitizing Agents; Prostatic Neoplasms; Protoporphyrins; Up-Regulation | 2006 |
Androgen induces expression of the multidrug resistance protein gene MRP4 in prostate cancer cells.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Dihydrotestosterone; Drug Resistance, Neoplasm; Gene Deletion; Gene Expression Regulation, Neoplastic; Humans; Male; Methotrexate; Multidrug Resistance-Associated Proteins; Prostatic Neoplasms; Receptors, Androgen; Tumor Cells, Cultured | 2007 |
Evidence of a novel antiapoptotic factor: role of inhibitor of differentiation or DNA binding (Id-1) in anticancer drug-induced apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma, Hepatocellular; Catechin; Cell Line, Tumor; Cell Survival; Cisplatin; Down-Regulation; Doxorubicin; Etoposide; Female; HeLa Cells; Humans; Inhibitor of Differentiation Protein 1; Liver Neoplasms; Male; Mechlorethamine; Methotrexate; Mitomycin; Nasopharyngeal Neoplasms; Paclitaxel; Prostatic Neoplasms; Vincristine | 2007 |
Intra-arterial infusion in tumors of the pelvis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Floxuridine; Fluorouracil; Humans; Iliac Artery; Infusions, Intra-Arterial; Leucovorin; Male; Melanoma; Methotrexate; Middle Aged; Ovarian Neoplasms; Pelvic Neoplasms; Prostatic Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms | 1983 |
The Nb rat prostatic adenocarcinoma's dose response to methotrexate and adriamycin.
Topics: Adenocarcinoma; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Doxorubicin; Male; Methotrexate; Neoplasm Metastasis; Prostatic Neoplasms; Rats | 1983 |
Adjuvant chemotherapy for stage D1 adenocarcinoma of prostate.
Topics: Adenocarcinoma; Antineoplastic Agents; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Follow-Up Studies; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Methotrexate; Patient Compliance; Prognosis; Prostatic Neoplasms; Stomatitis; Time Factors | 1983 |
Treatment of advanced prostate cancer with cyclophosphamide, doxorubicin, and methotrexate.
Topics: Acid Phosphatase; Aged; Alkaline Phosphatase; Bone and Bones; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Humans; Lung; Male; Methotrexate; Prognosis; Prostatic Neoplasms; Radiography; Time Factors | 1982 |
Chemotherapy of advanced, hormonally resistant prostatic carcinoma.
Topics: Antineoplastic Agents; Bone Marrow; Cisplatin; Drug Evaluation; Drug Resistance; Drug Therapy, Combination; Estramustine; Hormones; Humans; Male; Methotrexate; Prostatic Neoplasms; Semustine | 1980 |
Chemotherapy of hormone-resistant stage D prostatic cancer.
Topics: Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Estramustine; Fluorouracil; Humans; Hydroxyurea; Lomustine; Male; Melphalan; Methotrexate; Prednimustine; Prostatic Neoplasms | 1980 |
Androgen stimulated chemotherapy in the Dunning R-3327 prostatic adenocarcinoma.
Topics: Adenocarcinoma; Androgens; Animals; Body Weight; Castration; Cell Cycle; Male; Methotrexate; Neoplasms, Experimental; Prostatic Neoplasms; Rats; Testosterone; Time Factors | 1981 |
Evaluation of nonhormonal cytotoxic chemotherapy in the Nb rat (Pr-90) prostatic carcinoma.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cardiomyopathies; Cyclophosphamide; Doxorubicin; Drug Evaluation, Preclinical; Lung Neoplasms; Male; Methotrexate; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Rats | 1980 |
Evaluation of nonhormonal cytotoxic chemotherapy in the Nb rat prostate adenocarcinoma: autonomous tumor (18-Pr and 13-Pr).
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Evaluation, Preclinical; Fluorouracil; Male; Methotrexate; Neoplasm Transplantation; Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Rats; Time Factors | 1980 |
Evaluation of chemotherapeutic responsiveness in Nb rat prostate cancer model. 5-fluorouracil, methotrexate, cyclophosphamide, and adriamycin.
Topics: Animals; Cyclophosphamide; Doxorubicin; Fluorouracil; Male; Methotrexate; Neoplasms, Experimental; Prostatic Neoplasms; Rats | 1980 |
The non-hormone chemotherapy of prostatic cancer.
Topics: Bone Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Fluorouracil; Humans; Lung Neoplasms; Male; Methotrexate; Prostatic Neoplasms | 1980 |
[A case report of prostate cancer resistant to endocrine therapy successfully treated with intra-arterial chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Diethylstilbestrol; Doxorubicin; Drug Administration Schedule; Drug Resistance, Neoplasm; Granulocyte Colony-Stimulating Factor; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Male; Methotrexate; Prostatic Neoplasms; Remission Induction | 1995 |
[Comparative study on urinary parameters reflecting renal damage during chemotherapy for urological cancer].
Topics: Acetylglucosaminidase; Adolescent; Adult; Aged; Aminopeptidases; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD13 Antigens; Cisplatin; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Etoposide; Humans; Ifosfamide; Kidney Diseases; Male; Methotrexate; Middle Aged; Prostatic Neoplasms; Proteinuria; Urinary Bladder Neoplasms; Vincristine | 1993 |
[Leiomyosarcoma of the prostate: response to treatment with cisplatin, etoposide and methotrexate chemotherapy: a case report].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Humans; Leiomyosarcoma; Lung Neoplasms; Male; Methotrexate; Prostatic Neoplasms | 1994 |
[Transitional carcinoma of the prostate. Report of a case treated with chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Humans; Male; Methotrexate; Middle Aged; Prostatic Neoplasms; Vinblastine | 1993 |
Inhibition of growth of experimental prostate cancer in rats by LH-RH analogs linked to cytotoxic radicals.
Topics: Adenocarcinoma; Animals; Anthraquinones; Gonadotropin-Releasing Hormone; Male; Methotrexate; Neoplasm Transplantation; Prostatic Neoplasms; Rats; Tumor Cells, Cultured | 1993 |
Multidrug resistance in androgen-independent growing rat prostate carcinoma cells is mediated by P-glycoprotein.
Topics: Androgens; Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Fluorescent Dyes; Genes, MDR; Male; Methotrexate; Neoplasms, Hormone-Dependent; Paclitaxel; Prostatic Neoplasms; Rats; Rhodamine 123; Rhodamines; Tumor Cells, Cultured; Verapamil; Vinblastine | 1997 |
Mitoxantrone in the treatment of metastatic transitional cell carcinoma of the prostate. A case report.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Transitional Cell; Cisplatin; Disease Progression; Doxorubicin; Fatal Outcome; Follow-Up Studies; Humans; Injections, Intravenous; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitoxantrone; Prostatic Neoplasms; Remission Induction; Vinblastine | 1997 |
[Intraarterial chemotherapy via reservoir system for far-advanced bladder and prostate cancer].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Male; Methotrexate; Middle Aged; Prostatic Neoplasms; Urinary Bladder Neoplasms | 1998 |
[A case of primary transitional cell carcinoma of the prostate responsive to combination chemotherapy with methotrexate, epirubicin and cisplatin].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Drug Administration Schedule; Epirubicin; Humans; Male; Methotrexate; Prostatic Neoplasms; Remission Induction | 1998 |
Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells.
Topics: Antigens, Surface; Carboxypeptidases; Cell Fractionation; Cell Membrane; Folic Acid; gamma-Glutamyl Hydrolase; Glutamate Carboxypeptidase II; Humans; Hydrogen-Ion Concentration; Hydrolases; Immunohistochemistry; Male; Methotrexate; Polyglutamic Acid; Prostatic Neoplasms; Pteroylpolyglutamic Acids; Substrate Specificity; Tumor Cells, Cultured | 1996 |
Methotrexate-albumin conjugate causes tumor growth delay in Dunning R3327 HI prostate cancer-bearing rats.
Topics: Animals; Body Weight; Cell Division; Cell Line; Drug Carriers; Drug Resistance, Neoplasm; Humans; Lysosomes; Male; Methotrexate; Mice; Mice, Nude; Prostatic Neoplasms; Rats; Serum Albumin; Tissue Distribution; Transplantation, Heterologous | 1999 |
Tubulocystic clear cell adenocarcinoma arising within the prostate.
Topics: Adenocarcinoma, Clear Cell; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Fluorouracil; Humans; Immunohistochemistry; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Proteins; Prostatic Neoplasms; Testicular Neoplasms | 2000 |
[The solid-phase synthesis of methotrexate-alpha-peptides].
Topics: Antineoplastic Agents; History, Medieval; Humans; Male; Methotrexate; Phenylalanine; Prodrugs; Prostatic Neoplasms; Tumor Cells, Cultured | 1997 |
Pre-clinical evaluation of a methotrexate-albumin conjugate (MTX-HSA) in human tumor xenografts in vivo.
Topics: Adult; Aged; Animals; Antineoplastic Agents; Drug Evaluation; Female; Humans; Male; Maximum Tolerated Dose; Methotrexate; Mice; Mice, Nude; Middle Aged; Neoplasm Transplantation; Neoplasms, Experimental; Prostatic Neoplasms; Sarcoma; Serum Albumin; Transplantation, Heterologous | 2001 |
[Minimally invasive therapy for bladder and prostate cancer].
Topics: Administration, Intravesical; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Cisplatin; Cystoscopy; Humans; Laparoscopy; Male; Methotrexate; Prostatectomy; Prostatic Neoplasms; Radiotherapy Dosage; Ultrasonic Therapy; Urinary Bladder; Urinary Bladder Neoplasms | 2001 |
Transport of methotrexate into PC-3 human prostate cancer cells.
Topics: Binding, Competitive; Biological Transport, Active; Buffers; Carrier Proteins; Chlorides; Folic Acid; Humans; Hydrogen-Ion Concentration; Kinetics; Male; Methotrexate; Prostatic Neoplasms; Tumor Cells, Cultured | 2001 |
The chemotherapy of urologic cancer.
Topics: Adenocarcinoma; Adult; Aged; Alkylating Agents; Antineoplastic Agents; Doxorubicin; Drug Therapy, Combination; Estradiol; Female; Floxuridine; Fluorouracil; Humans; Hydroxyurea; Kidney Neoplasms; Male; Methotrexate; Middle Aged; Mitomycins; Plicamycin; Prostatic Neoplasms; Testicular Neoplasms; Thiotepa; Urinary Bladder Neoplasms; Urogenital Neoplasms; Vincristine | 1975 |
Therapeutic manipulation of Nb rat prostatic adenocarcinomas: chemotherapeutic evaluation of autonomous tumors.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cyclophosphamide; Doxorubicin; Evaluation Studies as Topic; Fluorouracil; Male; Methotrexate; Neoplasm Transplantation; Prostatic Neoplasms; Rats; Rats, Inbred Strains | 1979 |
Chemotherapy trial with comp-F regimen in advanced adenocarcinoma of prostate.
Topics: Adenocarcinoma; Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Fluorouracil; Humans; Male; Methotrexate; Neoplasm Metastasis; Prednisone; Prostatic Neoplasms; Retrospective Studies; Vincristine | 1978 |
Further experience with chemotherapy in the Dunning prostatic adenocarcinoma.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Asparaginase; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Fluorouracil; Hybridization, Genetic; Hydroxyurea; Lomustine; Male; Methotrexate; Neoplasms, Experimental; Platinum; Prostatic Neoplasms; Rats | 1978 |
[Combination cytostatic chemotherapy of advanced metastatic cancer of the prostate. A preliminary uncontrolled study].
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Bone Marrow Diseases; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms; Time Factors; Vincristine | 1977 |
Multiple drug chemotherapy regimen for patients with hormonally-unresponsive carcinoma of the prostate: a preliminary report.
Topics: Administration, Oral; Antineoplastic Agents; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Estrogens; Fluorouracil; Follow-Up Studies; Humans; Injections, Intravenous; Male; Melphalan; Methotrexate; Neoplasm Metastasis; Prednisone; Prostatic Neoplasms; Vincristine | 1977 |
Serial carcinoembryonic antigen assays in patients with metastatic carcinoma of prostate being treated with chemotherapy.
Topics: Acid Phosphatase; Adenocarcinoma; Carcinoembryonic Antigen; Drug Therapy, Combination; Fluorouracil; Humans; Male; Melphalan; Methotrexate; Neoplasm Metastasis; Prednisone; Prostatic Neoplasms; Vincristine | 1976 |
Is methotrexate therapy for psoriasis carcinogenic? A modified retrospective-prospective analysis.
Topics: Aged; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Liver; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasms; Prospective Studies; Prostatic Neoplasms; Psoriasis; Retrospective Studies; Skin Neoplasms | 1975 |
Short-chain analogs of luteinizing hormone-releasing hormone containing cytotoxic moieties.
Topics: Amino Acid Sequence; Animals; Anthraquinones; Antineoplastic Agents; Breast Neoplasms; Cell Membrane; Cell Survival; Cisplatin; Doxorubicin; Female; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Male; Melphalan; Methotrexate; Molecular Sequence Data; Oligopeptides; Orchiectomy; Pituitary Gland; Prostatic Neoplasms; Rats; Receptors, LHRH; Structure-Activity Relationship; Tumor Cells, Cultured | 1992 |
[The effectiveness of anal submucosal injection of methotrexate for relapsed prostatic cancer--a case report].
Topics: Adenocarcinoma; Aged; Anal Canal; Antineoplastic Agents; Castration; Combined Modality Therapy; Humans; Injections; Male; Methotrexate; Neoplasm Recurrence, Local; Prostatic Neoplasms | 1992 |
CMV chemotherapy for advanced transitional cell carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Female; Humans; Kidney Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prostatic Neoplasms; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vinblastine | 1992 |
Combination chemotherapy with methotrexate, bleomycin and cisplatin for advanced squamous cell carcinoma of the male genital tract.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Genital Neoplasms, Male; Humans; Lymphatic Metastasis; Male; Methotrexate; Perineum; Prostatic Neoplasms; Remission Induction; Scrotum; Skin Neoplasms; Time Factors; Tomography, X-Ray Computed | 1991 |
[A case report of relapsed stage D2 prostate cancer successfully treated with intraarterial chemotherapy].
Topics: Adenocarcinoma; Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Doxorubicin; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Male; Methotrexate; Prostate-Specific Antigen; Prostatic Neoplasms | 1991 |
Low-dose fortnightly methotrexate in advanced prostate cancer. The EORTC Genito-Urinary Tract Cancer Cooperative Group.
Topics: Aged; Drug Evaluation; Humans; Male; Methotrexate; Middle Aged; Prostatic Neoplasms | 1990 |
The effect of an anti-membrane antibody-methotrexate conjugate on the human prostatic tumour line PC3.
Topics: Animals; Cell Line; Cell Membrane; Cell Survival; Drug Carriers; Humans; Immunoglobulin G; Male; Methotrexate; Mice; Mice, Nude; Neoplasm Transplantation; Prostatic Neoplasms; Tumor Cells, Cultured | 1990 |
Low dose methotrexate and doxorubicin in hormone-resistant prostatic cancer. Scottish Urological Oncology Group.
Topics: Aged; Aged, 80 and over; Analgesics; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Resistance; Hormones; Humans; Male; Methotrexate; Middle Aged; Pain Measurement; Prostatic Neoplasms; Quality of Life | 1990 |
Growth modulation effects of synthetic steroids on rat prostatic adenocarcinoma and human breast adenocarcinoma cells in vitro.
Topics: Animals; Breast Neoplasms; Cell Division; Cell Survival; Drug Screening Assays, Antitumor; Hormones; Humans; Male; Methotrexate; Prostatic Neoplasms; Rats; Tumor Cells, Cultured | 1990 |
Primary transitional cell carcinoma of prostate: case with lymph node metastasis eradicated by neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prostatic Neoplasms; Vinblastine | 1990 |
[Intra-arterial chemotherapy of relapsed and hormone-resistant prostate cancer using reservoir system].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Resistance; Hormones; Humans; Infusion Pumps; Infusions, Intra-Arterial; Male; Methotrexate; Neoplasm Recurrence, Local; Prostatic Neoplasms; Survival Rate | 1990 |
In vitro synergism between hybrid immunotoxins and chemotherapeutic drugs: relevance to immunotherapy of prostate carcinoma.
Topics: Antibodies, Monoclonal; Bleomycin; Carcinoma; Cell Survival; Cells, Cultured; Combined Modality Therapy; Doxorubicin; Humans; Immunotherapy; Male; Methotrexate; Prostatic Neoplasms; Ricin; Vinblastine | 1986 |
[Chemotherapy of carcinoma of the prostate and testis: experimental study in vivo and in vitro].
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Line; Cisplatin; Cytarabine; Etoposide; Fluorouracil; Male; Methotrexate; Mice; Mice, Nude; Neoplasm Transplantation; Peplomycin; Prostatic Neoplasms; Testicular Neoplasms; Tumor Cells, Cultured; Tumor Stem Cell Assay; Vinblastine; Vincristine | 1988 |
[Lung metastases of prostatic cancer vanished by early combined hormonal and chemotherapy: report of a case].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Estramustine; Humans; Lung Neoplasms; Male; Methotrexate; Orchiectomy; Prostatic Neoplasms; Proteoglycans; Tegafur; Uracil | 1989 |
Advanced prostatic carcinoma: pulmonary manifestations.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Fluorouracil; Humans; Lung; Lung Neoplasms; Lymphatic Metastasis; Male; Melphalan; Methotrexate; Middle Aged; Pleural Effusion; Prednisone; Prostatic Neoplasms; Radiography; Retrospective Studies; Vincristine | 1985 |
Chemotesting of prostate cancer in xenografts.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cisplatin; Cyclophosphamide; Doxorubicin; Humans; Male; Methotrexate; Prostatic Neoplasms; Rats; Subrenal Capsule Assay | 1989 |
[Chemotherapy of advanced prostate cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bromocriptine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cyproterone; Cyproterone Acetate; Fluorouracil; Humans; Male; Methotrexate; Neoplasm Staging; Orchiectomy; Prognosis; Prostatic Neoplasms | 1986 |
Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for extravesical urinary tract tumors.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prostatic Neoplasms; Ureteral Neoplasms; Urethral Neoplasms; Urologic Neoplasms; Vinblastine | 1988 |
Effects of cyclophosphamide alone and scheduled methotrexate-5-fluorouracil combination chemotherapy on transplantable R-3327 prostatic adenocarcinoma in F1 hybrid male rat.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Fluorouracil; Male; Methotrexate; Neoplasm Transplantation; Prostatic Neoplasms; Rats | 1987 |
Effect of methotrexate-monoclonal anti-prostatic acid phosphatase antibody conjugate on human prostate tumor.
Topics: Acid Phosphatase; Animals; Antibodies, Monoclonal; Deoxyuridine; Folic Acid Antagonists; Humans; Immunoglobulin G; Male; Methotrexate; Mice; Mice, Nude; Prostate; Prostatic Neoplasms; Tritium | 1986 |
The effects of cyclophosphamide, ketoconazole, aclacinomycin-A, methotrexate, and scheduled methotrexate-5-fluorouracil combination chemotherapy on the transplantable R-3327 prostatic adenocarcinoma in the F1 hybrid male rat.
Topics: Aclarubicin; Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Administration Schedule; Fluorouracil; Ketoconazole; Male; Methotrexate; Naphthacenes; Neoplasm Transplantation; Prostatic Neoplasms; Rats | 1985 |
Nb rat prostate adenocarcinoma model: evaluation of the subrenal capsular assay system.
Topics: Adenocarcinoma; Animals; Cisplatin; Cyclophosphamide; Disease Models, Animal; Doxorubicin; Histological Techniques; Kidney Neoplasms; Male; Methotrexate; Neoplasm Transplantation; Prostatic Neoplasms; Rats; Rats, Inbred Strains | 1985 |
Cytotoxic chemotherapy and androgen priming in patients with advanced carcinoma of the prostate. A phase II trial of the Piedmont Oncology Association.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Drug Evaluation; Fluoxymesterone; Humans; Leukopenia; Male; Methotrexate; Middle Aged; Prostatic Neoplasms; Vincristine | 1985 |
Chemotherapy of vesical and prostatic tumours.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Bleomycin; Cobalt Isotopes; Cystitis; Daunorubicin; Ethoglucid; Fluorouracil; Humans; Hydroxyurea; Male; Methotrexate; Mitomycins; Nitrogen Mustard Compounds; Papilloma; Prostatic Neoplasms; Thiotepa; Urinary Bladder Neoplasms | 1971 |
Lactate dehydrogenase isoenzymes in hyperplasia and carcinoma of the prostate: a clinical study.
Topics: Body Fluids; Carcinoma; Diethylstilbestrol; Electrophoresis; Humans; In Vitro Techniques; Isoenzymes; L-Lactate Dehydrogenase; Male; Methotrexate; Prostatic Hyperplasia; Prostatic Neoplasms; Spectrophotometry; Tissue Extracts | 1967 |
The effect of cytostatic therapy with cyclophosphamide alone or in combination with methotrexate on the phytohaemagglutinin lymphocyte culture and on the immunoglobulins.
Topics: Adult; Aged; Breast Neoplasms; Bronchial Neoplasms; Cyclophosphamide; Female; gamma-Globulins; Humans; Immunoglobulins; Lectins; Liver Neoplasms; Lung Neoplasms; Lymphocytes; Male; Methotrexate; Middle Aged; Prostatic Neoplasms | 1970 |
Prostatic tumor acid phosphatase production. Influence of antineoplastic agents.
Topics: Acid Phosphatase; Aged; Alkaline Phosphatase; Antineoplastic Agents; Aspartate Aminotransferases; Blood Glucose; Blood Urea Nitrogen; Cyclophosphamide; Cytarabine; Dactinomycin; Drug Therapy, Combination; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Plicamycin; Prostatic Neoplasms; Thiotepa | 1973 |
Current problems in the use of the oncolytic drugs.
Topics: Antineoplastic Agents; Busulfan; Carcinoma, Squamous Cell; Child; Chlorambucil; Choriocarcinoma; Dactinomycin; Female; Fluorouracil; Gonadal Steroid Hormones; Hodgkin Disease; Humans; Hydrazines; Leukemia; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Mesenchymoma; Methotrexate; Multiple Myeloma; Nitrogen Mustard Compounds; Ovarian Neoplasms; Pregnancy; Prostatic Neoplasms; Steroids; Testicular Neoplasms; Urethane; Vinblastine; Vincristine; Wilms Tumor | 1968 |
Complete regression of metastatic tumors of the adult with antimitotic treatment.
Topics: Adolescent; Adult; Antineoplastic Agents; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Female; Follow-Up Studies; Head and Neck Neoplasms; Hemangiosarcoma; Humans; Infant; Lung Neoplasms; Male; Mechlorethamine; Mercaptopurine; Methotrexate; Middle Aged; Neoplasm Metastasis; Pregnancy; Prostatic Neoplasms; Sarcoma; Teratoma; Testicular Neoplasms; Thoracic Neoplasms; Thyroid Neoplasms; Triaziquone; Uterine Neoplasms; Vinblastine | 1974 |
Fluoride therapy for pain in malignant bone disease.
Topics: Adult; Aged; Analgesia; Bone Neoplasms; Breast Neoplasms; Estrogens; Fluorides; Fluoxymesterone; Humans; Male; Methotrexate; Middle Aged; Multiple Myeloma; Neoplasm Metastasis; Paraganglia, Nonchromaffin; Prednisone; Prostatic Neoplasms; Thiotepa | 1968 |